RPRX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Repros Therapeutics Inc's cash flow from others for the six months ended in Sep. 2016 was $0.00 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2016 was $0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Repros Therapeutics Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2016 was $0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Repros Therapeutics Inc Annual Data
|Cash Flow from Others||9.86||-17.65||0.00||0.73||-0.16||0.00||-0.01||-0.00||0.00||0.00|
Repros Therapeutics Inc Semi-Annual Data
|Cash Flow from Others||-0.00||0.00||-0.00||0.00||0.00||0.00||-0.00||-0.00||0.00||0.00|